Merck follows Bristol’s suit, pulling Keytruda’s SCLC nod. Is the FDA’s accelerated approval reckoning finally here?

Merck follows Bristol’s suit, pulling Keytruda’s SCLC nod. Is the FDA’s accelerated approval reckoning finally here?
aliu
Tue, 03/02/2021 – 07:02